Skip to main content
MedWatcherBeta

Loading research and source information…

This is an Extension Study of the Roche P-trials to Investigate Safety and Effectiveness of Ocrelizumab in Participants With Multiple Sclerosis (MS) for Multiple sclerosis: evidence and status · MedWatcher